Crossmark

Transpulmonary pressure monitoring in critically ill patients: pros and cons—correction of description of the non-invasive PEEP-step method for separation of lung and chest wall mechanics

Crossref DOI link: https://doi.org/10.1186/s13054-024-05125-5

Published Online: 2024-11-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stenqvist, Ola
License Information

Text and Data Mining valid from 2024-11-04

Version of Record valid from 2024-11-04
More Information

Article History

Received: 30 September 2024

Accepted: 6 October 2024

First Online: 4 November 2024

Declarations

:

: Not applicable.

: Not applicable.

: OS holds shares in the Lung Barometry AB (LBAB), which owns the commercial rights to the PSM technology. LBAB has recently entered into an agreement to commercialize the PEEP-step method with a Med Tech company.

Document is current

Any future updates will be listed below